Podcast: An Integrated Development and Commercialization Process for New Medicines

John Glasspool, CEO and President of Anthos Therapeutics met with Steve Crom to discuss the challenges of giving patients access to new medicines.

Steve Crom
Steve Crom
For 35 years, I have supported leaders and organizations in achieving sustainable breakthroughs in performance.
1 minute
15 June, 2021

Podcast: An Integrated Development and Commercialization Process for New Medicines

The P5 Approach with John Glasspool (Anthos Therapeutics)

John Glasspool, CEO and President of Anthos Therapeutics met with Steve Crom to discuss the challenges of giving patients access to new medicines. Payers, Professionals, Providers and Policymakers all influence patient access; hence, what is needed is an approach to development and commercialization that integrates the needs of all involved – the P5 process.

Watch here and learn more about the advantages of this approach.

Leave a comment

Stay in touch